Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications

Patients with non-small cell lung cancer (NSCLC) develop bone metastasis (BoM) in more than 50% of cases during the course of the disease. This metastatic site can lead to the development of skeletal related events (SREs), such as severe pain, pathological fractures, spinal compression, and hypercal...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Conte, Alessandro, De Carlo, Elisa, Bertoli, Elisa, Stanzione, Brigida, Revelant, Alberto, Bertola, Manuela, Spina, Michele, Bearz, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224636/
https://www.ncbi.nlm.nih.gov/pubmed/35743275
http://dx.doi.org/10.3390/ijms23126832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224636/
https://www.ncbi.nlm.nih.gov/pubmed/35743275
http://dx.doi.org/10.3390/ijms23126832

Ejemplares similares